Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nihal El Rouby

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
NEJM Evidence|September 23, 2025
Pharmacogenetic Testing - Evidence, Challenges, and Pathways to AdoptionNihal El Rouby, Julie A Johnson
Current Hypertension Reports|July 23, 2015
Genetics of resistant hypertension: a novel pharmacogenomics phenotypeNihal El Rouby, Rhonda M Cooper-DeHoff
Expert Opinion on Drug Metabolism & Toxicology|April 6, 2018
Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicineNihal El Rouby, John J Lima, Julie A Johnson
The Annals of Pharmacotherapy|July 20, 2019
Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract InfectionsKevin Cowart, Marylee Worley, Nihal El Rouby, et al.
Genetic Testing and Molecular Biomarkers|February 14, 2019
Development and Cross-Validation of High-Resolution Melting Analysis-Based Cardiovascular Pharmacogenetics Genotyping PanelTaimour Langaee, Nihal El Rouby, Lynda Stauffer, et al.
Clinical and Translational Science|November 3, 2021
Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populationsNihal El Rouby, Mohamed H Shahin, Loulia Bader, et al.
Stem Cells (Dayton, Ohio)|January 19, 2017
Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision MedicineTakashi Hamazaki, Nihal El Rouby, Natalie C Fredette, et al.
Clinical and Translational Science|July 30, 2024
Pharmacogenomics polygenic risk score: Ready or not for prime time?Sonal Singh, Gabriele Stocco, Katherine N Theken, et al.
Pharmacogenetics and Genomics|June 20, 2014
The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotypingTaimour Y Langaee, Hao-Jie Zhu, Xinwen Wang, et al.
Clinical and Translational Science|April 22, 2025
Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS)Nihal El Rouby, Aniwaa Owusu-Obeng, Michael H Preuss, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
NEJM Evidence|September 23, 2025
Pharmacogenetic Testing - Evidence, Challenges, and Pathways to AdoptionNihal El Rouby, Julie A Johnson
Current Hypertension Reports|July 23, 2015
Genetics of resistant hypertension: a novel pharmacogenomics phenotypeNihal El Rouby, Rhonda M Cooper-DeHoff
Expert Opinion on Drug Metabolism & Toxicology|April 6, 2018
Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicineNihal El Rouby, John J Lima, Julie A Johnson
The Annals of Pharmacotherapy|July 20, 2019
Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract InfectionsKevin Cowart, Marylee Worley, Nihal El Rouby, et al.
Genetic Testing and Molecular Biomarkers|February 14, 2019
Development and Cross-Validation of High-Resolution Melting Analysis-Based Cardiovascular Pharmacogenetics Genotyping PanelTaimour Langaee, Nihal El Rouby, Lynda Stauffer, et al.
Clinical and Translational Science|November 3, 2021
Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populationsNihal El Rouby, Mohamed H Shahin, Loulia Bader, et al.
Stem Cells (Dayton, Ohio)|January 19, 2017
Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision MedicineTakashi Hamazaki, Nihal El Rouby, Natalie C Fredette, et al.
Clinical and Translational Science|July 30, 2024
Pharmacogenomics polygenic risk score: Ready or not for prime time?Sonal Singh, Gabriele Stocco, Katherine N Theken, et al.
Pharmacogenetics and Genomics|June 20, 2014
The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotypingTaimour Y Langaee, Hao-Jie Zhu, Xinwen Wang, et al.
Clinical and Translational Science|April 22, 2025
Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS)Nihal El Rouby, Aniwaa Owusu-Obeng, Michael H Preuss, et al.
Pageof 4